Yeo Jung Moon

Investment Division Director

40 past transactions

LINER

Series B in 2024
LINER is a pioneering company in the field of artificial intelligence, specifically focusing on enhancing productivity through its AI-powered search engine. Known as Asia's first AI agent, LINER's platform utilizes large language model technology to perform a variety of complex tasks, streamlining the research process for users. Its unique highlighter database allows for efficient information management, significantly reducing research time from hundreds of minutes to mere seconds. Serving a global user base, with over 94% of its clientele located outside Korea, LINER operates in more than 100 countries. The company aims to help users collect and develop insights more effectively, thereby improving overall productivity.

Aimedbio

Series B in 2024
Aimedbio is a healthcare company focused on developing therapeutic solutions for patients suffering from serious brain diseases. The company specializes in creating therapeutic systems and medicines aimed at treating neuro-oncological and degenerative conditions. By addressing the needs of patients with refractory brain diseases, including cancer, Aimedbio strives to enhance their quality of life through innovative treatment options.

Feature

Seed Round in 2024
Feature operates an entertainment studio focused on transforming traditional television into immersive metaverse experiences. By utilizing blockchain technology and proprietary tools, Feature enhances marketing, engagement, and loyalty for creators and brands. Their innovative web3 video stack enables the conversion of passive viewers into identifiable users, fostering a direct connection between creators and their audiences. Additionally, the company provides interactive minting capabilities, blockchain-enabled gaming, and social media integration, allowing for the development of Web3 native content. This approach positions Feature as a key player in the evolving landscape of digital interaction and content delivery.

Mobilint

Series B in 2024
Mobilint specializes in artificial intelligence-powered chip technology aimed at enhancing deep neural networks and AI applications. The company focuses on delivering integrated sensor fusion and deep learning system-on-chip (SoC) solutions. By vertically integrating co-optimized algorithms, software, and hardware technologies, Mobilint offers accelerated AI solutions that improve performance and programmability. This approach enables clients to achieve end-to-end acceleration in integrated semiconductor services, particularly for applications related to autonomous driving.

Clodot

Venture Round in 2023
Clodot is an information technology company.

OncoResponse

Venture Round in 2023
OncoResponse Inc. is an immuno-oncology biotechnology company based in Houston, Texas, focused on developing innovative cancer therapies. The company utilizes a proprietary human antibody platform to identify fully human monoclonal antibodies targeting immuno-oncology pathways. By probing the adaptive immune systems of cancer patients who have shown exceptional responses to checkpoint inhibitors, OncoResponse aims to discover novel therapeutic antibodies. Its research emphasizes addressing immunosuppressive myeloid biology and enhancing immune activation, with the goal of transforming cold tumors into hot tumors that are more responsive to treatment. Through its advanced antibody pipeline, OncoResponse is dedicated to providing effective solutions for cancer treatment.

Wirobotics

Seed Round in 2023
Wirobotics develops wearable robot technology aimed at enhancing musculoskeletal health and reducing physical strain on the body. Their innovative robotic products utilize flexible mechanisms and high-performance actuators, allowing them to closely conform to the user's body. By incorporating task monitoring and analysis, Wirobotics quantifies labor intensity and workload, helping organizations improve workplace safety and efficiency. The company's solutions are designed to promote active motion while ensuring that physical demands are managed effectively, thus fostering a healthier work environment.

Fazz

Series C in 2022
Fazz is a financial technology company based in Singapore and Indonesia, founded in 2016. It focuses on providing digital financial services to enhance financial inclusion across Southeast Asia, particularly targeting underserved segments such as micro and small enterprises. Fazz offers a range of services including payment processing, banking, and investment solutions tailored for small businesses, startups, and large corporations. Its flagship offerings include Fazz Agen, an agent-based financial application designed for micro and small businesses, and Fazz Business, a comprehensive business account that facilitates payments, capital growth, and funding opportunities. The merger of PayFazz and Xfers has strengthened Fazz's position in the fintech landscape, enabling it to deliver diverse financial services to consumers and businesses alike.

Dot

Series B in 2022
Dot Pad — The first tactile graphics display for the visually impaired. (https://www.youtube.com/watch?v=DaxlpMj1sxU) Dot Kiosk - The most accessible kiosk for the disabled and everyone in a smart city.

LinqAlpha

Pre Seed Round in 2022
LinqAlpha is a GenAI-native market intelligence and analytics platform built specifically for hedge funds. Developed by MIT/Harvard PhDs and ex-investment professionals, it automates key aspects of equity research, enabling analysts to efficiently search, analyze, and interpret complex financial data. Already used by several of the top global hedge fund platforms, LinqAlpha enhances decision-making and accelerates research productivity with its finance-specific AI search models.

Ybrain

Private Equity Round in 2022
Ybrain Inc. is a South Korean company founded in 2013, specializing in the development of wearable devices that utilize neuroscience technology to address brain disorders and enhance mental well-being. The company focuses on creating solutions for patients with Alzheimer’s and mild cognitive impairment, as well as those suffering from neuropsychiatric illnesses such as Major Depressive Disorder (MDD). Ybrain's products include a wireless EEG system that facilitates the collection of brain signal data and a non-invasive brain stimulation device that employs weak electrical currents to stimulate brain activity. Currently, the company is conducting clinical trials in Korea and is also working on a big data platform that leverages brain signals collected through its proprietary qEEG software, aiming to provide more targeted and personalized treatment options.

iN Therapeutics

Series B in 2022
iN Therapeutics is a biotechnology company focused on developing innovative drug therapies for patients with incurable neurological diseases. The company is engaged in the creation of treatments targeting various conditions, including non-narcotic analgesics for Nav1.7, hearing loss, and other brain-related disorders. By advancing its drug development pipeline, iN Therapeutics aims to provide effective solutions for central nervous system diseases, ultimately enhancing the quality of life for affected individuals.

H2O Hospitality

Series C in 2021
H2O Hospitality, Ltd. is a hospitality management company based in Seoul, South Korea, specializing in the Korean and Japanese markets. Established in 2015, it is recognized as the largest vacation rental management company in its region. H2O Hospitality offers a range of services including profit management, housekeeping and facility management, customer call response, online sales and marketing, as well as reservation and inventory management. The company utilizes an innovative property management system (PMS) that automates operational flows by linking calendars between guests, rooms, and housekeepers, thereby significantly reducing fixed operational costs and enhancing facility yield. Additionally, H2O Hospitality provides digital management solutions to streamline operations for vacation rental properties, facilitating bookings from various online travel agencies and optimizing customer attraction.

Mobilint

Series A in 2021
Mobilint specializes in artificial intelligence-powered chip technology aimed at enhancing deep neural networks and AI applications. The company focuses on delivering integrated sensor fusion and deep learning system-on-chip (SoC) solutions. By vertically integrating co-optimized algorithms, software, and hardware technologies, Mobilint offers accelerated AI solutions that improve performance and programmability. This approach enables clients to achieve end-to-end acceleration in integrated semiconductor services, particularly for applications related to autonomous driving.

Publy

Series B in 2021
PUBLY is an online content platform tailored for working individuals, offering subscription services that facilitate access to curated content. The platform specializes in creating, designing, archiving, and publishing custom content and events, which users can reserve for future reference. This enables users to purchase and publish content from various media sources, providing a convenient way to access and manage relevant information. By focusing on the needs of professionals, PUBLY aims to enhance the content consumption experience for its users.

Ably

Series B in 2021
Ably Corporation operates a fashion platform that enables customers to buy and sell products among themselves. The platform features a forum where influencers and celebrities can establish online stores to showcase and sell their products. This model allows users to stay informed about the latest fashion trends and purchase clothing items similar to those worn by their favorite public figures. Ably aims to create a community-driven marketplace that connects consumers with the fashion choices of influential personalities.

Catch Table

Series B in 2021
Catch Table is a restaurant reservation management platform that offers online reservation services to customers. It allows users to filter restaurant options based on various criteria, including date, number of guests, cost, food category, and table type. The platform also provides additional information such as valet parking and corkage services, making it easier for customers to find the right dining experience. By enabling real-time reservations, Catch Table streamlines the process of booking tables in restaurants, facilitating a more efficient dining experience for both customers and restaurant operators.

My Chef

Series B in 2021
My Chef sells home meal kits.

Gridwiz

Series C in 2021
Gridwiz is an energy company that specializes in delivering efficient and sustainable energy services to its clients. The company focuses on power demand management, helping users optimize their energy consumption. Additionally, Gridwiz manufactures and sells electric vehicle charging modems and chargers, supporting the growing demand for electric mobility. The company is also involved in the installation and operational management of energy storage systems (ESS) and solar power generation facilities, contributing to the transition towards renewable energy sources. Through its diverse offerings, Gridwiz aims to enhance energy efficiency and promote environmentally friendly practices in the energy sector.

DoctorHere

Series A in 2020
DoctorHere is a smart medical clinic using AI and IT to provide primary care both in-person and virtually

Evidnet

Series A in 2020
EvidNet is a healthcare IT company focused on providing Real World Evidence (RWE) solutions derived from hospital data, aimed at enhancing research and business decision-making within the life sciences and healthcare sectors. Collaborating with over 50 university and general hospitals in Korea, EvidNet builds Real World Data (RWD) following the OMOP-CDM standard. Their FeederNet® data platform supports multi-institutional research and AI federated machine learning while ensuring privacy and security. The company specializes in managing clinical practice data through an interoperable, real-time integrated healthcare data network, offering tailored statistical analysis that meets the specific needs of hospitals and clients. By leveraging these advanced technologies, EvidNet delivers valuable insights that span from research and development to commercialization, ultimately contributing to the advancement of precision and predictive medicine.

Riiid

Series D in 2020
Riiid is a global innovator in AI-powered education solutions, specializing in adaptive assessment platforms that personalize learning experiences for students worldwide. Launched in 2017 with Santa TOEIC, its flagship product has reached over one million users in Korea alone, demonstrating proven efficacy. Expanding globally, Riiid operates Santa TOEIC in Japan and offers Santa SAT in Vietnam. Its scalable AI technology provides each student with a personalized tutor, enhancing learning outcomes while reducing costs compared to traditional methods. By democratizing educational opportunities, Riiid is rapidly transforming the learning landscape.

FamePick

Series A in 2019
FamePick Inc. is a subscription-based platform established in 2016 and located in Sunnyvale, California, that serves the advertising and marketing industry. It specializes in facilitating celebrity-driven marketing campaigns on social media, enabling businesses to effectively connect with audiences. The platform offers seasoned creators and influencers a suite of tools designed to help them manage their personal brands while maintaining their narrative and integrity. These tools assist users in identifying like-minded partners, strengthening relationships, and diversifying their presence across various platforms and media. Additionally, FamePick provides a custom automated media kit that includes audience reach, demographics, rates, and recent brand collaborations, empowering creators to enhance their market value and grow their businesses.

Aerodyne

Series B in 2019
Aerodyne Group is a global leader in drone-based enterprise solutions, specializing in DT3 technologies (Drone Tech, Data Tech, Digital Transformation). With over 1000 drone professionals, they have managed more than 560,000 infrastructure assets across 32 countries, conducting over 458,000 flight operations. Aerodyne offers large-scale data operations and analytics for industries like power infrastructure inspection, wind turbines, and solar farms, optimizing processes and increasing productivity. Recognized globally for its innovations, the company has been awarded Frost & Sullivan's 'Asia Pacific UAV Services Company of 2019' and IET Malaysia's 'Industry Excellence Gold Award 2019'. Its founder and Group CEO, Kamarul A Muhamed, is a recipient of prestigious awards such as EY's Entrepreneur of the Year 2020.

Finda

Series A in 2019
Finda, Inc. is a data-driven online comparison platform based in Seoul, South Korea, specializing in various financial products such as mortgages, personal loans, and investments. The company enables users to compare different financial offerings by collecting and analyzing data from multiple industries, including the automobile finance sector. Finda's platform not only helps users identify suitable financial products but also provides economic calculation services related to housing loans, monthly savings, and loan repayment. By focusing on delivering customized financial information, Finda aims to empower individuals to make informed financial decisions in a timely manner.

Sualab

Series C in 2019
Sualab focuses on developing artificial intelligence-based solutions aimed at enhancing industrial efficiency through automation. The company specializes in a smart factory system that employs AI-driven image analysis technology to automate tasks traditionally performed by humans. By providing unmanned automatic inspection and process optimization, Sualab's systems are tailored for industries such as textiles, leather, and steel. This innovation allows businesses to monitor and control key variables, ensuring optimal process conditions and increasing productivity while minimizing human intervention. Through its research and development, Sualab aims to leverage technology to improve operational value and efficiency.

Orum Therapeutics

Series B in 2019
Orum Therapeutics is a private biotechnology company based in Daejeon, South Korea, founded in 2016. The company specializes in the research and development of therapeutic antibodies through its innovative cell-penetrating antibody platform, Oromab™. This platform is designed to target cytosolic proteins, addressing unmet medical needs in cancer and rare genetic diseases. Orum's unique approach allows for the intracellular delivery of active antibody therapeutics or payloads, enabling the inhibition of drug targets that have been previously considered undruggable by conventional small molecules or antibody therapies. Orum's technology is adaptable to various cell types and intracellular proteins without requiring chemical modifications, aiming to develop effective treatments with improved specificity and reduced toxicity.

Medi Plus Solution

Series A in 2019
MediPlus Solution is a digital healthcare service provider focused on enhancing the recovery and quality of life for patients with serious conditions such as stomach, colorectal, breast, and prostate cancers. Its primary offering, Second Doctor, includes a comprehensive rehabilitation program that integrates exercise regimens, nutrition management, medication oversight, and educational resources tailored to individual patient needs. The company also provides a bidirectional medical support system aimed at chronic patients, which connects physicians, caregivers, and patients to facilitate real-time health monitoring and effective disease management. Through these services, MediPlus Solution aims to deliver personalized healthcare that supports quick recovery and improves overall health outcomes.

Publy

Series B in 2019
PUBLY is an online content platform tailored for working individuals, offering subscription services that facilitate access to curated content. The platform specializes in creating, designing, archiving, and publishing custom content and events, which users can reserve for future reference. This enables users to purchase and publish content from various media sources, providing a convenient way to access and manage relevant information. By focusing on the needs of professionals, PUBLY aims to enhance the content consumption experience for its users.

Intelon Optics

Series A in 2018
Intelon Optics, Inc. is a bio-mechanical diagnostic and surgical device company that specializes in designing and developing innovative eye diagnostic optical solutions. Based in Lexington, Massachusetts, with a manufacturing facility in Rochester, New York, the company focuses on the Brillouin Optical Scanner System. This advanced optical-scanning diagnostic platform is aimed at determining the intrinsic biomechanical properties of both transparent and opaque ocular tissues, including the cornea, sclera, and lens. The device enhances point-by-point biomechanical imaging of eye structures, allowing eye care professionals to offer a variety of novel diagnostic and surgical services tailored to individual patient needs. Since its incorporation in 2015, Intelon Optics has positioned itself at the forefront of eye disease treatment technology.

Sparkplus

Series A in 2018
Sparkplus, founded in 2016 and based in Seoul, South Korea, specializes in providing comprehensive solutions for office environments. The company designs and manages real estate contracts, interior design, construction, and furniture arrangements specifically for coworking spaces. By addressing various challenges faced by businesses regarding their office needs, Sparkplus aims to streamline the process, enabling clients to focus on their core activities without the distraction of managing their office setup.

ExoCoBio

Series B in 2018
ExoCoBio Inc. is a South Korean company founded in 2017 that specializes in the development of biopharmaceuticals and cosmeceuticals derived from stem cell-derived exosomes. These nano-vesicles play a crucial role in intercellular signaling, facilitating skin and tissue regeneration. ExoCoBio focuses on creating innovative therapeutics and cosmetic products aimed at enhancing health and promoting regeneration, particularly in skin and hair. By leveraging the unique properties of exosomes, the company aims to provide effective alternatives in regenerative medicine and improve overall well-being.

Caxe

Series C in 2018
Caxe Technologies specializes in providing technology solutions for financial services, primarily targeting blue-chip B2B clients. The company has developed a data and AI-based platform that offers a range of services, including digital banking software, credit decision-making tools, analytics, risk management, and regulatory reporting. By integrating these capabilities, Caxe enables clients to enhance their operational efficiency and make informed financial decisions through improved digital sales and distribution strategies.

Neuraly

Series A in 2018
Neuraly, Inc. is a clinical-stage biotechnology company based in Germantown, Maryland, focused on discovering and developing innovative treatments for neurodegenerative diseases, including Parkinson's and Alzheimer's diseases. Founded in 2016, Neuraly emerged from research conducted by leading neuroscientists, notably Ted Dawson at Johns Hopkins School of Medicine. The company is known for its neuroprotective agent NLY01, which targets the pathological activation of microglia, and also develops two blood-brain barrier-penetrating kinase inhibitors, NLY02 and NLY03. Neuraly's approach emphasizes the crucial role of glial cells in neurodegenerative disease progression, aiming to prevent neuronal cell death and enhance the quality of life for affected individuals.

JLK

Venture Round in 2018
JLK, Inc. is a South Korean company that specializes in AI-driven solutions for medical diagnosis and security. The firm develops an artificial intelligence medical analysis platform that provides on-site and real-time services connected to various hospital systems, addressing the diagnostic needs of healthcare professionals. JLK's offerings encompass medical management, treatment, and services related to brain diseases, such as ischemic stroke, hemorrhagic stroke, brain aneurysm, and Alzheimer’s disease, as well as conditions affecting the lungs, coronary artery disease, prostate cancer, and digital pathology. Headquartered in Cheongju, South Korea, JLK aims to enhance healthcare delivery through its advanced technological solutions.

Dot

Venture Round in 2018
Dot Pad — The first tactile graphics display for the visually impaired. (https://www.youtube.com/watch?v=DaxlpMj1sxU) Dot Kiosk - The most accessible kiosk for the disabled and everyone in a smart city.

Orum Therapeutics

Series A in 2017
Orum Therapeutics is a private biotechnology company based in Daejeon, South Korea, founded in 2016. The company specializes in the research and development of therapeutic antibodies through its innovative cell-penetrating antibody platform, Oromab™. This platform is designed to target cytosolic proteins, addressing unmet medical needs in cancer and rare genetic diseases. Orum's unique approach allows for the intracellular delivery of active antibody therapeutics or payloads, enabling the inhibition of drug targets that have been previously considered undruggable by conventional small molecules or antibody therapies. Orum's technology is adaptable to various cell types and intracellular proteins without requiring chemical modifications, aiming to develop effective treatments with improved specificity and reduced toxicity.

ImmunoMet Therapeutics

Series B in 2017
ImmunoMet Therapeutics, Inc. is a biopharmaceutical company based in Houston, Texas, that develops and commercializes innovative oncology drugs aimed at enhancing the quality of life for cancer patients. Founded in 2015, the company focuses on creating metabolic regulators that target the cellular metabolism of drug-resistant cancer subpopulations, as well as immuno-suppressors designed to modulate anti-cancer effector T cells. With over six years of expertise in cancer metabolism and immunometabolism, ImmunoMet is committed to advancing its comprehensive pipeline to address the challenges faced by patients with resistant forms of cancer.

The Pinkfong Company

Series A in 2015
The Pinkfong Company is a global entertainment firm that specializes in creating and distributing engaging content for audiences worldwide. Renowned for its award-winning brands and intellectual properties, the company offers a diverse range of entertainment experiences, including original animated series, live tours, and interactive games. By focusing on the dual goals of enjoyment and education, The Pinkfong Company aims to inspire and connect people of all ages, fostering joyful experiences and learning opportunities through its innovative content.

IGAWorks

Series C in 2014
IGAWorks is a full-stack ad-tech company established in 2006, specializing in supporting digital marketing and mobile businesses. The company offers a comprehensive suite of services that includes Tradingworks, a media and audience trade desk; adbrix, an all-in-one data platform for mobile growth based on advertising and user performance; and adPOPcorn, Korea’s largest advertising network. Additionally, IGAWorks provides Mobile Index, a mobile app market analytics platform, and Campaign Intelligence, a reporting tool that streamlines marketers' reporting processes. With its integrated mobile platform, IGAWorks enables publishers to monetize their applications effectively by offering analytics, mobile attribution, marketing automation, and market intelligence solutions. Currently, over 30,000 mobile applications utilize IGAWorks' offerings to enhance their business growth.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.